Capgras Syndrome associated with the use of psychoactive substances

被引:4
|
作者
Mercurio, Ezequiel N. [1 ]
机构
[1] Hosp Neuropsiquiatr Braulio A Moyano, Buenos Aires, DF, Argentina
来源
关键词
Capgras syndrome; Facial processing; Prosopagnosia; Frontotemporal cortex; Substance abuse; DELUSIONAL MISIDENTIFICATION SYNDROMES; PSYCHOTIC SYMPTOMS; ALZHEIMERS-DISEASE; LEWY BODIES; RECOGNITION; FACES; FAMILIARITY; TOMOGRAPHY; DISORDERS; KNOWLEDGE;
D O I
10.1016/j.rpsm.2011.02.002
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Capgras syndrome has originally been described as psychiatric syndrome. However, in the last few years reports of patients with this syndrome has significantly increased in patients with neurological, metabolic, and infectious diseases and those who consume alcohol. Different hypotheses have been proposed to explain the neurobiology of this very unusual symptom, such as changes in the dopamine circuit and specific dysfunctions in facial processing. Case: In this work we present a new case of Capgras syndrome, associated with an acute cocaine overdose, which was transient and reversible. Discussion: The neurobiological bases of this syndrome are analysed, along with their relationship with the changes induced by cocaine use. Thus, Capgras syndrome could be the expression of functional changes at frontal-temporal level, and the paralimbic region secondary to the consumption of psychoactive substances such as cocaine. (C) 2010 SEP y SEPB. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:96 / 100
页数:5
相关论文
共 50 条
  • [1] Cognitive deterioration associated with the use of different psychoactive substances
    Coullaut-Valera, Rafael
    Arbaiza-Diaz del Rio, Iria
    de Arrue-Ruiloba, Ricardo
    Coullaut-Valera, Juan
    Bajo-Breton, Ricardo
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2011, 39 (03): : 168 - 173
  • [2] Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances
    Wood, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S541 - S541
  • [3] Novel Psychoactive Substances: How to Understand the Acute Toxicity Associated With the Use of These Substances
    Wood, David M.
    Dargan, Paul I.
    [J]. THERAPEUTIC DRUG MONITORING, 2012, 34 (04) : 363 - 367
  • [4] Techno+, preventing the risks associated with the use of psychoactive substances
    Faure, Sebastien
    [J]. ACTUALITES PHARMACEUTIQUES, 2022, 61 (621): : 5 - 5
  • [5] The Use of Psychoactive Substances in Germany
    Rauschert, Christian
    Mockl, Justin
    Seitz, Nicki-Nils
    Wilms, Nicolas
    Olderbak, Sally
    Kraus, Ludwig
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (31-32): : 527 - +
  • [6] USE OF PSYCHOACTIVE SUBSTANCES BY RESIDENTS
    MADDUX, JF
    TIMMERMAN, IM
    COSTELLO, RM
    [J]. JOURNAL OF MEDICAL EDUCATION, 1987, 62 (10): : 852 - 854
  • [7] Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances
    Deligianni, Elena
    Daniel, Omari J.
    Corkery, John M.
    Schifano, Fabrizio
    Lione, Lisa A.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (03) : 505 - 516
  • [8] Use of psychoactive substances by goods carriage drivers associated with Kerala, India
    Siva Prasad, M. S.
    Priyatha, C. V.
    K. Joseph, Jayesh
    Aneesh, E. M.
    [J]. TRAFFIC INJURY PREVENTION, 2023,
  • [9] Use of psychoactive substances by goods carriage drivers associated with Kerala, India
    Prasad, M. S. Siva
    Priyatha, C. V.
    Joseph, Jayesh K.
    Aneesh, E. M.
    [J]. TRAFFIC INJURY PREVENTION, 2023, 24 (08) : 663 - 669
  • [10] Use of psychoactive substances by pharmacy students
    Klotz, C.
    Beignon, M.
    Haramburu, F.
    Baumevieille, M.
    Daveluy, A.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 79 - 79